Results 11 to 20 of about 4,868 (171)

Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program

Antimicrobial Stewardship & Healthcare Epidemiology, 2023
Objective: To determine whether a structured OPAT program supervised by an infectious disease physician and led by an OPAT nurse decreased hospital readmission rates and OPAT-related complications and whether it affected clinical cure.
Gaurav Agnihotri, Alan E. Gross, Minji Seok, Cheng Yu Yen, Farah Khan, Laura M. Ebbitt, Cassandra Gay, Susan C. Bleasdale, Monica K. Sikka, Andrew B. Trotter   +9 more
doaj   +2 more sources

Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center

Antimicrobial Stewardship & Healthcare Epidemiology, 2023
Background: Outpatient antimicrobial therapy (OPAT) is managed by a variety of teams, but primarily through an infectious disease clinic. At our medical center, OPAT monitoring is performed telephonically by pharmacists through a collaborative practice ...
Taylor M. Epperson, Kiya K. Bennett, Katherine K. Kupiec, Kathy Speigel, Stephen B. Neely, Beth H. Resman-Targoff, Karen K. Kinney, Bryan P. White   +7 more
doaj   +2 more sources

Safety and Efficacy of Outpatient Parenteral Antibiotic Therapy (OPAT) in Patients With Infective Endocarditis: A Systematic Review and Meta‐Analysis

Clinical Cardiology, Volume 48, Issue 5, May 2025.
ABSTRACT Background Infective endocarditis (IE) is a life‐threatening infection requiring prolonged intravenous antimicrobial therapy. Outpatient parenteral antibiotic therapy (OPAT) has emerged as an alternative to prolonged hospitalization, but its safety and efficacy in IE remain debated.
Hamza Ashraf, Zain Ali Nadeem, Khawaja Abdul Rehman, Shanzay Akhtar, Haider Ashfaq, Muhammad Sohaib Khan, Mahad Butt, Ibrahim Nagmeldin, Eeshal Fatima, Muhammad Waqas, Aalaa Saleh, Hritvik Jain, Raheel Ahmed   +12 more
wiley   +2 more sources

Cost evaluation of a nurse coordinated outpatient parenteral antimicrobial therapy (OPAT) program

Antimicrobial Stewardship & Healthcare Epidemiology, 2023
A structured, nurse-driven outpatient parenteral antimicrobial therapy (OPAT) program within an academic healthcare system was associated with reduced odds of 60-day unplanned OPAT readmissions and costs after hospital discharge.
Huiwen Deng, Alan E. Gross, Andrew B. Trotter, Daniel R. Touchette   +3 more
doaj   +2 more sources

The Impact of a Structured Outpatient Parenteral Antimicrobial Therapy (OPAT) Programme on Quality of Care, Optimisation of Antimicrobial Use, and Healthcare Costs: A Retrospective Cohort Study

Antibiotics
Background/Objectives: In 2022, Spaarne Gasthuis hospital implemented an outpatient parenteral antimicrobial therapy (OPAT) programme, including mandatory infectious disease (ID) specialist assessment and integrated structured workflow, aiming to improve
Irene G. Manders, Darya Comello, Dennis Souverein, Sjoerd Euser, Bjorn L. Herpers, Judith Vetten, Jayant S. Kalpoe, Marco Goeijenbier, Steven F. L. van Lelyveld   +8 more
doaj   +2 more sources

Exploring patients’ perspectives: a mixed methods study on Outpatient Parenteral Antimicrobial Therapy (OPAT) experiences

BMC Health Services Research
Background Outpatient Parenteral Antimicrobial Therapy (OPAT), an alternative to inpatient intravenous antibiotic therapy, has shown benefits in international studies such as increased patient satisfaction. Because OPAT has been used only sporadically in
Sophie Peter, Charlotte Oberröhrmann, Holger Pfaff, Clara Lehmann, Kirsten Schmidt-Hellerau, Vanessa Brandes, Charlotte Leisse, Christoph Heinrich Lindemann, Peter Ihle, Jutta Küpper-Nybelen, Anna Hagemeier, Nadine Scholten   +11 more
doaj   +2 more sources

Exploring the advancements of Australian OPAT

Therapeutic Advances in Infectious Disease, 2023
Outpatient parenteral antimicrobial therapy (OPAT) in Australia has evolved from modest beginnings to a well-established health service with proven benefits in patient outcomes.
Tony Lai, Horst Thiele, Benjamin A. Rogers, Nadine Hillock, Suman Adhikari, Alexander McNamara, Matthew Rawlins   +6 more
doaj   +1 more source

From sea to shining IV: the current state of OPAT in the United States

Therapeutic Advances in Infectious Disease, 2023
First described in the United States, outpatient parenteral antibiotic therapy (OPAT) has become an indispensable part of treating serious infections. The proportion of infectious disease (ID) physicians utilizing a formal OPAT program has increased in ...
Jeffrey Larnard, Kyleen Swords, Dan Taupin, Simi Padival   +3 more
doaj   +1 more source

Palliative outpatient parenteral antimicrobial therapy (OPAT): A single center experience and systematic scoping review

Clinical Infection in Practice, 2022
Traditionally, outpatient parenteral antimicrobial therapy (OPAT) is used to treat infections with predictable course and anticipated response to therapy. However, there has been little consideration of OPAT for palliation as opposed to cure.
Oyewole Chris Durojaiye, Ihsan Jibril, Evangelos I Kritsotakis   +2 more
doaj   +1 more source

My patient needs home IV antibiotics–Now what? Assessing OPAT involvement at a Veterans’ Affairs hospital

Antimicrobial Stewardship & Healthcare Epidemiology, 2022
Background: Outpatient parenteral antimicrobial therapy (OPAT) involves the administration of intravenous antimicrobial therapy outside the hospital. The literature suggests that inpatient providers are often unaware of OPAT programs and may not engage ...
Maddy Breeden, Elizabeth Scruggs, Payal Patel, Sarah Krein, Ronald Kendall, Andrea Starnes, Tracy Lopus   +6 more
doaj   +1 more source